R-3327-3.1 cell line
Invented at Johns Hopkins University
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 156407 |
| Antigen/Gene or Protein Targets | Gives rise to malignant cells with a high rate of metastasis in lymph nodes and lung |
| Disease Keywords | Cancer |
| Model | Cancer Model |
| Relevance | AT-3 originates from the spontaneous tumor (R3327) of the prostate identified by W.F. Dunning in a 22 month-old inbred Copenhagen male rat in 1961. R3327 has been maintained by continuous serial passage in rats for many years. Following subcutaneous transplantation in syngeneic male rats, AT-3 forms solid sheets of malignant cells with no indication of glandular function. AT-3.1 tumors grow continuously with a doubling time of 1.5-1.8 days regardless of the androgen status of the host and exhibit a high rate of metastasis to the lung and lymph nodes (>75% of rats inoculated sub-cutaneously develop distant metastases). The AT-3 subline can be used to study the effects of various types of cancer therapies on prostate cells. Together AT-3 and the related Dunning sublines also provide a valuable model for studying prostate malignancies both in vitro and in vivo. |
| Research Area | Cancer, Drug Discovery & Development |
| Cellosaurus ID | CVCL_3570 |
References: 2 entries
Ichikawa et al. 1992. Cancer Res. 52(12):3486-90. PMID: 1596907.
Ichikawa et al. 1991. Cancer Res. 51(14):3788-92. PMID: 2065333.
Add a reference
References: 2 entries
Ichikawa et al. 1992. Cancer Res. 52(12):3486-90. PMID: 1596907.
Ichikawa et al. 1991. Cancer Res. 51(14):3788-92. PMID: 2065333.
Add a reference
